Fibroblast growth factor 2 isoforms and cardiac hypertrophy

Cardiovascular Research

Volumn 63, Issue 3, 2004, Pages 458-466

  Kardami, Elissavet ^a   Jiang, Zhi Sheng ^a   Jimenez, Sarah K ^a   Hirst, Cheryl J ^a   Sheikh, Farah ^a   Zahradka, Peter ^a   Cattini, Peter A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardiac hypertrophy; CUG FGF 2; FGF 2 signal transduction; Intracrine signaling

Indexed keywords

ANGIOTENSIN; FIBROBLAST GROWTH FACTOR 2;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HUMAN; MALADJUSTMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STRESS; UPREGULATION;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; FIBROBLAST GROWTH FACTOR 2; HUMANS; MYOCARDIUM; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

EID: 3242793341     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.04.024     Document Type: Review

References (75)

1. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341:1999;1276-1283
2. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:2003;45-79
3. Nadal-Ginard B., Kajstura J., Leri A., Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92:2003;139-150
4. Molkentin J.D., Dorn I.G. II Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63:2001;391-426
5. Akazawa H., Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 92:2003;1079-1088
6. Lips D.J., deWindt L.J., van Kraaij D.J., Doevendans P.A. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 24:2003;883-896
7. Hannan R.D., Jenkins A., Jenkins A.K., Brandenburger Y. Cardiac hypertrophy: a matter of translation. Clin. Exp. Pharmacol. Physiol. 30:2003;517-527
8. Detillieux K.A., Sheikh F., Kardami E., Cattini P.A. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc. Res. 57:2003;8-19
9. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol. 2(3):2001;. reviews 3005.1-3005.12
10. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 468:2000;6-10
11. Piotrowicz R.S., Ding L., Maher P., Levin E.G. Inhibition of cell migration by 24-kDa fibroblast growth factor-2 is dependent upon the estrogen receptor. J. Biol. Chem. 276:2001;3963-3970
12. Szebenyi G., Fallon J.F. Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185:1999;45-106
13. Jimenez S.K., Sheikh F., Jin Y., et al. Transcriptional regulation of FGF-2 Gene expression in cardiac myocytes. Cardiovasc. Res. 2004;. [in press]
14. Stachowiak E.K., Fang X., Myers J., Dunham S., Stachowiak M.K. cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J. Neurochem. 84:2003;1296-1312
15. Jin Y., Sheikh F., Detillieux K.A., Cattini P.A. Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes. Mol. Pharmacol. 57:2000;984-990
16. Vagner S., Gensac M.C., Maret A., et al. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15:1995;35-44
17. Prats A.C., Prats H. Translational control of gene expression: role of IRESs and consequences for cell transformation and angiogenesis. Prog. Nucleic Acid Res. Mol. Biol. 72:2002;367-413
18. Arnaud E., Touriol C., Boutonnet C., et al. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol. Cell. Biol. 19:1999;505-514
19. Bonnal S., Schaeffer C., Creancier L., et al. A single internal ribosome entry site containing a G quartet RNA structure drives fibroblast growth factor 2 gene expression at four alternative translation initiation codons. J. Biol. Chem. 278:2003;39330-39336
20. Clarke M.S., Caldwell R.W., Chiao H., Miyake K., McNeil P.L. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ. Res. 76:1995;927-934
21. Kaye D., Pimental D., Prasad S., et al. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J. Clin. Invest. 97:1996;281-291
22. Sheikh F., Sontag D.P., Fandrich R.R., Kardami E., Cattini P.A. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1039-H1050
23. Taverna S., Ghersi G., Ginestra A., et al. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J. Biol. Chem. 278:2003;51911-51919
24. Klint P., Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci. 4:1999;D165-D177
25. Jin Y., Pasumarthi K.B., Bock M.E., Lytras A., Kardami E., Cattini P.A. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J. Mol. Cell. Cardiol. 26:1994;1449-1459
26. Kardami E., Liu L., Kishore S., Pasumarthi B., Doble B.W., Cattini P.A. Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. Ann. N. Y. Acad. Sci. 752:1995;353-369
27. Liu L., Pasumarthi K.B., Padua R.R., et al. Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am. J. Physiol. 268:1995;H1927-H1938
28. Tanaka K., Abe M., Sato Y. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn. J. Cancer Res. 90:1999;647-654
29. Padua R.R., Merle P.L., Doble B.W., et al. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J. Mol. Cell. Cardiol. 30:1998;2695-2709
30. Braz J.C., Bueno O.F., DeWindt L.J., Molkentin J.D. PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J. Cell Biol. 156:2002;905-919
31. Pass J.M., Zheng Y., Wead W.B., et al. PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H946-H955
32. Liang Q., Molkentin J.D. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 35:2003;1385-1394
33. Olson E.N., Schneider M.D. Sizing up the heart: development redux in disease. Genes Dev. 17:2003;1937-1956
34. Bueno O.F., Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91:2002;776-781
35. Han J., Molkentin J.D. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc. Med. 10:2000;19-22
36. Kozawa O., Tokuda H., Matsuno H., Uematsu T. Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J. Cell. Biochem. 74:1999;479-485
37. Merle P.L., Feige J.J., Verdetti J. Basic fibroblast growth factor activates calcium channels in neonatal rat cardiomyocytes. J. Biol. Chem. 270:1995;17361-17367
38. Jiang Z.S., Padua R.R., Ju H., et al. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H1071-H1080
39. Huang S.L., Ding B., Li J., Yu Q.S., Guo Z.G. Antisense Ca(2+)-calmodulin dependent protein kinase oligonucleotide inhibits bFGF-induced proliferation of rat vascular smooth muscle cells. Acta Pharmacol. Sin. 21:2000;229-233
40. Tomono M., Toyoshima K., Ito M., Amano H., Kiss Z. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Arch. Biochem. Biophys. 353:1998;374-378
41. Vega R.B., Bassel-Duby R., Olson E.N. Control of cardiac growth and function by calcineurin signaling. J. Biol. Chem. 278:2003;36981-36984
42. Hirai T., Chida K. Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J. Biochem. (Tokyo). 133:2003;1-7
43. Pullen N., Thomas G. The modular phosphorylation and activation of p70s6k. FEBS Lett. 410:1997;78-82
44. Bailly K., Soulet F., Leroy D., Amalric F., Bouche G. Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor. FASEB J. 14:2000;333-344
45. Holnthoner W., Pillinger M., Groger M., et al. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J. Biol. Chem. 277:2002;45847-45853
46. Antos C.L., McKinsey T.A., Frey N., et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 99:2002;907-912
47. Torsoni A.S., Constancio S.S., Nadruz W. Jr., Hanks S.K., Franchini K.G. Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ. Res. 93:2003;140-147
48. Shah B.H., Catt K.J. A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol. Sci. 24:2003;239-244
49. Maher P.A. Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:1996;529-536
50. Reilly J.F., Maher P.A. Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J. Cell Biol. 152:2001;1307-1312
51. Stachowiak M.K., Fang X., Myers J.M., et al. Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. J. Cell. Biochem. 90:2003;662-691
52. Kardami E., Fandrich R.R. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J. Cell Biol. 109:1989;1865-1875
53. Pasumarthi K.B., Kardami E., Cattini P.A. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ. Res. 78:1996;126-136
54. Claus P., Doring F., Gringel S., et al. Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J. Biol. Chem. 278:2003;479-485
55. Bossard C., Laurell H., Van den Berghe L., Meunier S., Zanibellato C., Prats H. Translokin is an intracellular mediator of FGF-2 trafficking. Nat. Cell Biol. 5:2003;433-439
56. Amalric F., Bouche G., Bonnet H., et al. Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets. Biochem. Pharmacol. 47:1994;111-115
57. Bouche G., Baldin V., Belenguer P., Prats H., Amalric F. Activation of rDNA transcription by FGF-2: key role of protein kinase CKII. Cell. Mol. Biol. Res. 40:1994;547-554
58. Brandenburger Y., Jenkins A., Autelitano D.J., Hannan R.D. Increased expression of UBF is a critical determinant for rRNA synthesis and hypertrophic growth of cardiac myocytes. FASEB J. 15:2001;2051-2053
59. Hirst C.J., Herlyn M., Cattini P.A., Kardami E. High levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death. Mol. Cell. Biochem. 246:2003;111-116
60. Sun G., Doble B.W., Sun J.M., et al. CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. J. Cell. Physiol. 186:2001;457-467
61. Nindl W., Kavakebi P., Claus P., Grothe C., Pfaller K., Klimaschewski L. Expression of basic fibroblast growth factor isoforms in postmitotic sympathetic neurons: synthesis, intracellular localization and involvement in karyokinesis. Neuroscience. 124:2004;561-572
62. Parker T.G., Packer S.E., Schneider M.D. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85:1990;507-514
63. Corda S., Mebazaa A., Gandolfini M.P., et al. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ. Res. 81:1997;679-687
64. Pellieux C., Foletti A., Peduto G., et al. Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J. Clin. Invest. 108:2001;1843-1851
65. Schultz J.E., Witt S.A., Nieman M.L., et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J. Clin. Invest. 104:1999;709-719
66. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5672-5677
67. Dono R., Texido G., Dussel R., Ehmke H., Zeller R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17:1998;4213-4225
68. Fiebeler A., Schmidt F., Muller D.N., et al. Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension. 37:2001;787-793
69. Liu L., Doble B.W., Kardami E. Perinatal phenotype and hypothyroidism are associated with elevated levels of 21.5- to 22-kDa basic fibroblast growth factor in cardiac ventricles. Dev. Biol. 157:1993;507-516
70. Coffin J.D., Florkiewicz R.Z., Neumann J., et al. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell. 6:1995;1861-1873
71. Doble B.W., Fandrich R.R., Liu L., Padua R.R., Kardami E. Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases. Biochem. Biophys. Res. Commun. 173:1990;1116-1122
72. Jiang Z.S., Kardami E. The CUG-initiated FGF-2 delivered to the ischemic myocardium during infarction, causes significant myocardial hypertrophy as well as cardioprotection. J. Mol. Cell. Cardiol. 35:2003;A35
73. Padua R.R., Kardami E. Increased basic fibroblast growth factor (bFGF) accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury. Growth Factors. 8:1993;291-306
74. Peng H., Moffett J., Myers J., et al. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol. Biol. Cell. 12:2001;449-462
75. Peng H., Myers J., Fang X., et al. Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J. Neurochem. 81:2002;506-524